Skip to main content

Table 2 Comparison of clinical parameters and comorbidities in the both groups

From: Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study

Clinical parameters and comorbidities

Discharged patients (n  =  298)

Death (n  =  62)

Total (n  =  360)

p

Age (years)

 < 60 years

226 (75.7%)

17 (27.1%)

199 (55.2%)

< 0.001

 > 60 years

72 (24.3%)

45 (72.9%)

161 (44.8%)

Sex

 Male

134 (45%)

37 (59.6%)

184 (51.0%)

0.023

 Female

164 (55%)

25 (40.4%)

176 (49.0%)

URS

 Yes

164 (55%)

53 (86.4%)

245 (68.2%)

0.033

 No

134 (45%)

9 (13.6%)

115 (31.8%)

Dyspnea

 Yes

113 (37.9%)

39 (62.6%)

169 (46.9%)

< 0.001

 No

185 (62.1%)

23 (37.4%)

191 (51.9%)

Headache

 Yes

28 (9.3%)

7 (11.1%)

36 (10.0%)

0.072

 No

270 (90.7%)

55 (88.9%)

324 (90.0%)

Hypertension

 Yes

39 (12.9%)

29 (46.5%)

96 (26.8%)

< 0.001

 No

259 (87.1%)

33 (53.5%)

263 (73.2%)

Diabetes

 Yes

24 (7.9%)

13 (20.2%)

47 (13.0%)

< 0.001

 No

274 (92.1%)

49 (79.8%)

313 (87.0%)

Coronary heart disease

 Yes

9 (2.9%)

11 (17.5%)

32 (8.8%)

0.014

 No

289 (97.1%)

51 (82.5%)

328 (91.2%)

Pulmonary comorbidities

 Yes

15 (5%)

7 (12.1%)

29 (7.9%)

0.32

 No

283 (95%)

55 (87.9%)

331 (92.1%)

Time to admission (days)

 > 6

130 (43.6%)

43 (68.7%)

194 (54.0%)

< 0.001

 ≤ 6

168 (56.4%)

19 (31.3%)

166 (46.0%)

Hospital days (days)

 > 7

249 (83.6%)

16 (26.3%)

215 (59.8%)

< 0.001

 ≤ 7

48 (16.4%)

45 (73.7%)

144 (40.2%)

  1. URS upper respiratory symptoms; p p value